Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Survey: Women with uterine fibroids largely unaware of minimally invasive treatment option

U.S. women are largely unaware of uterine fibroid embolization (UFE), a minimally invasive treatment for uterine fibroids that is less painful, preserves the uterus and allows women to get back to their lives sooner than surgical options, according to results from a new nationwide poll released today by the Society of Interventional Radiology.

29 Aug 2017

Incisionless surgery method can safely treat painful bone tumors, study shows

Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).

24 Aug 2017

Study disrupts conventional wisdom that uterine fibroids cause miscarriages

A 10-year study, led by Vanderbilt University Medical Center professor of Obstetrics and Gynecology Katherine Hartmann, M.D., Ph.D., disrupts conventional wisdom that uterine fibroids cause miscarriages.

8 Jun 2017

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

For the first time since the corresponding law became effective in 2012, the German Institute for Quality and Efficiency in Health Care has published an assessment of the potential of a new treatment method according to §137e of Social Code Book V.

23 Mar 2017

Clinical study tests efficacy of new focused ultrasound-based treatment for breast fibroadenoma

Patients with benign breast tumors may be eligible for a new focused ultrasound-based investigational treatment as part of a pivotal, multi-center clinical study. The trial began last month at the University of Virginia Medical Center.

20 Mar 2017

U-M joins $20 million project to compare treatments for uterine fibroids

The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids.

15 Oct 2016

UVA researchers begin first clinical trial using focused ultrasound to treat patients with epilepsy

Researchers at the University of Virginia are starting the first clinical trial in the world using focused ultrasound to treat patients with epilepsy.

29 Sep 2016

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the treatment of essential tremor

INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, has announced that the New England Journal of Medicine (NEJM) has published the results of a pivotal study of their Exablate Neuro system for the non-invasive treatment of essential tremor (ET). The study met its primary endpoint with patients treated with Exablate Neuro demonstrating a clinically significant 47% improvement in a composite tremor score at three months as compared to no change in the sham cohort.

29 Aug 2016

BU researcher receives grant to better understand breast cancer in African-American women

Why do African-American women die at a higher rate and experience more aggressive breast tumors than white women? Researchers from Boston University's Slone Epidemiology Center (SEC) have received funding from the National Cancer Institute to explore this question.

6 Jul 2016

Women who undergo uterine fibroid embolization experience improved sexual function

Women who underwent a nonsurgical, image-guided treatment, uterine fibroid embolization (UFE), for the treatment of uterine fibroids experienced improved sexual function and a higher overall quality of life. The research, part of a French multicenter study, presented at the Society of Interventional Radiology's Annual Scientific Meeting, also found the vast majority of women treated with UFE sustained improvement for more than a year.

4 Apr 2016

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

BioSpecifics Technologies Corp., a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product collagenase clostridium histolyticum, or CCH, marketed as XIAFLEX in the U.S. and Xiapex in Europe, today announced its financial results for the fourth quarter and full year ended December 31, 2015 and provided a corporate update.

14 Mar 2016

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015.

12 Feb 2016

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.

29 Jan 2016

High testosterone levels in women may increase uterine fibroid risk

Women who have high levels of both testosterone and estrogen in midlife may face a greater risk of developing benign tumors on the uterus called uterine fibroids than women with low levels of the hormones, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

16 Dec 2015

Morgan brings industry-leading ceramics to HIFU transducers

Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.

10 Dec 2015

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

Boston Scientific has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies.

10 Nov 2015

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined prostate disease while preserving surrounding healthy tissue, without radiation or surgery.

14 Oct 2015

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Researchers at the University of Maryland and the University of Virginia have performed the first focused ultrasound treatments in the United States for dyskinesia associated with Parkinson's disease.

2 Sep 2015

Many reproductive-age women experience pelvic pain that goes untreated, study finds

A high proportion of reproductive-age women may be experiencing pelvic pain that goes untreated, according to a study by researchers from the National Institutes of Health and the University of Utah School of Medicine, Salt Lake City.

12 Aug 2015

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that Asahi Kasei Pharma Corporation has received approval for its regulatory application to the Japanese Pharmaceutical and Medical Device Agency (PMDA) for XIAFLEX (collagenase clostridium histolyticum) for the treatment of patients with Dupuytren's contracture in Japan.

20 Jul 2015

Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Survey: Women with uterine fibroids largely unaware of minimally invasive treatment option

Incisionless surgery method can safely treat painful bone tumors, study shows

Study disrupts conventional wisdom that uterine fibroids cause miscarriages

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

Clinical study tests efficacy of new focused ultrasound-based treatment for breast fibroadenoma

U-M joins $20 million project to compare treatments for uterine fibroids

UVA researchers begin first clinical trial using focused ultrasound to treat patients with epilepsy

Study results confirm safety and efficacy of INSIGHTEC’s Exablate Neuro system for the treatment of essential tremor

BU researcher receives grant to better understand breast cancer in African-American women

Women who undergo uterine fibroid embolization experience improved sexual function

BioSpecifics reports net income of $2.7 million for fourth quarter 2015

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

High testosterone levels in women may increase uterine fibroid risk

Morgan brings industry-leading ceramics to HIFU transducers

Boston Scientific signs definitive agreement to acquire CeloNova's interventional radiology business

SonaCare Medical's Sonablate 450 focused ultrasound system receives FDA approval for ablation of prostate tissue

Researchers perform first focused ultrasound treatments in the U.S. for dyskinesia

Many reproductive-age women experience pelvic pain that goes untreated, study finds

XIAFLEX approved in Japan for treatment of patients with Dupuytren's contracture

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in